Dr. Bruce D. Carter is a biological chemist and a Professor of Biochemistry at Vanderbilt University. Dr. Carter’s research interests focus on the molecular mechanisms of neurotrophin signaling. Specifically, he studies the signaling mechanisms regulating neuronal survival, as abnormal apoptosis is the basis for many neuropathologies including Alzheimer’s disease. Dr. Carter is a member of the training faculty for the Vanderbilt Interdisciplinary Training Program in Alzheimer’s Disease (T32).
Dr. Carter completed his doctoral degree in biological chemistry at University of Michigan and postdoctoral fellowships at Max Planck Institute and Cornell University Medical School. He joined the Vanderbilt faculty in 1997.